Skip to Content
Merck
  • Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK).

Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK).

Bioorganic & medicinal chemistry letters (2008-10-22)
Luc J Farmer, Guy Bemis, Shawn D Britt, John Cochran, Martin Connors, Edmund M Harrington, Thomas Hoock, William Markland, Suganthini Nanthakumar, Paul Taslimi, Ernst Ter Haar, Jian Wang, Darshana Zhaveri, Francesco G Salituro
ABSTRACT

A series of SYK inhibitors based on the phenylamino pyrimidine thiazole lead 4 were prepared and evaluated for biological activity. Lead optimization provided compounds with nanomolar K(i)'s against SYK and potent inhibition in mast cell degranulation assays.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
3-Methoxy-5-(trifluoromethyl)aniline, 99%